131 related articles for article (PubMed ID: 37166700)
41. Tissue transglutaminase in celiac disease: role of autoantibodies.
Caputo I; Barone MV; Martucciello S; Lepretti M; Esposito C
Amino Acids; 2009 Apr; 36(4):693-9. PubMed ID: 18600381
[TBL] [Abstract][Full Text] [Related]
42. Deamidated Gliadin Antibodies: Do They Add to Tissue Transglutaminase-IgA Assay in Screening for Celiac Disease?
Abdulrahim A; Fagih M; Troncone R; Bashir MS; Asery A; Alruwaithi M; Al-Jurayyan AN; Al-Alallah I; Al-Hussaini A
J Pediatr Gastroenterol Nutr; 2021 May; 72(5):e112-e118. PubMed ID: 33346579
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies.
Sayed SK; Imam HM; Mahran AM; Refaiy AM
Egypt J Immunol; 2012; 19(2):41-52. PubMed ID: 23885406
[TBL] [Abstract][Full Text] [Related]
44. Tissue transglutaminase--the key player in celiac disease: a review.
Reif S; Lerner A
Autoimmun Rev; 2004 Jan; 3(1):40-5. PubMed ID: 14871648
[TBL] [Abstract][Full Text] [Related]
45. Serum positivity of serum anti-tissue transglutaminase immunoglobulin A antibodies in Japanese children with inflammatory bowel disease.
Kurasawa S; Sado T; Kato S; Iwaya M; Nakayama Y
Pediatr Int; 2023 Jan; 65(1):e15485. PubMed ID: 36702637
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of BioPlex 2200 tTG-IgA Diagnostic Performance for Serology-Based Diagnosis of Celiac Disease.
Pacheco MC; Lee D; Dickerson J
Am J Clin Pathol; 2022 Jan; 157(1):136-139. PubMed ID: 34542555
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of celiac disease among first-degree relatives of patients with celiac disease.
Doğan Y; Yildirmaz S; Ozercan IH
J Pediatr Gastroenterol Nutr; 2012 Aug; 55(2):205-8. PubMed ID: 22241509
[TBL] [Abstract][Full Text] [Related]
48. Immunoproliferative small intestinal disease (IPSID) in Thailand.
Pramoolsinsap C; Kurathong S; Atichartakarn V; Nitiyanand P
Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):11-7. PubMed ID: 8362283
[TBL] [Abstract][Full Text] [Related]
49. High prevalence of celiac disease among Saudi children with type 1 diabetes: a prospective cross-sectional study.
Al-Hussaini A; Sulaiman N; Al-Zahrani M; Alenizi A; El Haj I
BMC Gastroenterol; 2012 Dec; 12():180. PubMed ID: 23259699
[TBL] [Abstract][Full Text] [Related]
50. Pan-Gastrointestinal Tract Mucosal Pathologies in Patients with Celiac Disease with the Demonstration of IgA Anti-Transglutaminase Mucosal Deposits: A Case-Control Study.
Chauhan A; Das P; Singh A; Dutta R; Rajeshwari M; Rajput MS; Agarwal A; Banyal V; Upadhay A; Ahuja V; Makharia G
Dig Dis Sci; 2022 Aug; 67(8):3649-3661. PubMed ID: 34499270
[TBL] [Abstract][Full Text] [Related]
51. Lack of Utility of Anti-tTG IgG to Diagnose Celiac Disease When Anti-tTG IgA Is Negative.
Absah I; Rishi AR; Gebrail R; Snyder MR; Murray JA
J Pediatr Gastroenterol Nutr; 2017 May; 64(5):726-729. PubMed ID: 28437323
[TBL] [Abstract][Full Text] [Related]
52. [Predictive value of serological tests in the diagnosis of celiac disease].
Carroccio A; Di Prima L; Falci C; Le Moli C; Soresi M; Montalto G; Notarbartolo A
Ann Ital Med Int; 2002; 17(2):102-7. PubMed ID: 12150043
[TBL] [Abstract][Full Text] [Related]
53. The industrial food additive, microbial transglutaminase, mimics tissue transglutaminase and is immunogenic in celiac disease patients.
Matthias T; Jeremias P; Neidhöfer S; Lerner A
Autoimmun Rev; 2016 Dec; 15(12):1111-1119. PubMed ID: 27640315
[TBL] [Abstract][Full Text] [Related]
54. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease.
Vahedi K; Mascart F; Mary JY; Laberenne JE; Bouhnik Y; Morin MC; Ocmant A; Velly C; Colombel JF; Matuchansky C
Am J Gastroenterol; 2003 May; 98(5):1079-87. PubMed ID: 12809831
[TBL] [Abstract][Full Text] [Related]
55. Autoantibodies to tissue transglutaminase as predictors of celiac disease.
Dieterich W; Laag E; Schöpper H; Volta U; Ferguson A; Gillett H; Riecken EO; Schuppan D
Gastroenterology; 1998 Dec; 115(6):1317-21. PubMed ID: 9834256
[TBL] [Abstract][Full Text] [Related]
56. Usefulness of a double immunofluorescence technique for detection of intestinal tTG-IgA deposits in diabetic and non-diabetic children with celiac disease.
Lal R; Bhardwaj R; Minz RW; Prasad KK; Lal S; Dayal D; Kumar Y
Pediatr Neonatol; 2023 Jul; 64(4):388-397. PubMed ID: 36610914
[TBL] [Abstract][Full Text] [Related]
57. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits.
Wong RC; Wilson RJ; Steele RH; Radford-Smith G; Adelstein S
J Clin Pathol; 2002 Jul; 55(7):488-94. PubMed ID: 12101191
[TBL] [Abstract][Full Text] [Related]
58. Prevalence of celiac disease in Tunisia: mass-screening study in schoolchildren.
Ben Hariz M; Kallel-Sellami M; Kallel L; Lahmer A; Halioui S; Bouraoui S; Laater A; Sliti A; Mahjoub A; Zouari B; Makni S; Maherzi A
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):687-94. PubMed ID: 17625439
[TBL] [Abstract][Full Text] [Related]
59. Antitissue transglutaminase and antithyroid autoantibodies in children with Down syndrome and celiac disease.
Hansson T; Dahlbom I; Rogberg S; Nyberg BI; Dahlström J; Annerén G; Klareskog L; Dannaeus A
J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):170-4; discussion 125-7. PubMed ID: 15699691
[TBL] [Abstract][Full Text] [Related]
60. High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue tranglutaminase autoantibodies.
Villalta D; Girolami D; Bidoli E; Bizzaro N; Tampoia M; Liguori M; Pradella M; Tonutti E; Tozzoli R
J Clin Lab Anal; 2005; 19(1):6-10. PubMed ID: 15645466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
